Atomistry » Zinc » PDB 3d7v-3dgm » 3ddb
Atomistry »
  Zinc »
    PDB 3d7v-3dgm »
      3ddb »

Zinc in PDB 3ddb: Crystal Structure of the Catalytic Domain of Botulinum Neurotoxin Serotype A with A Substrate Analog Peptide

Enzymatic activity of Crystal Structure of the Catalytic Domain of Botulinum Neurotoxin Serotype A with A Substrate Analog Peptide

All present enzymatic activity of Crystal Structure of the Catalytic Domain of Botulinum Neurotoxin Serotype A with A Substrate Analog Peptide:
3.4.24.69;

Protein crystallography data

The structure of Crystal Structure of the Catalytic Domain of Botulinum Neurotoxin Serotype A with A Substrate Analog Peptide, PDB code: 3ddb was solved by D.Kumaran, S.Swaminathan, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 32.42 / 1.60
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 50.871, 66.581, 65.062, 90.00, 98.34, 90.00
R / Rfree (%) 20 / 21.8

Zinc Binding Sites:

The binding sites of Zinc atom in the Crystal Structure of the Catalytic Domain of Botulinum Neurotoxin Serotype A with A Substrate Analog Peptide (pdb code 3ddb). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Crystal Structure of the Catalytic Domain of Botulinum Neurotoxin Serotype A with A Substrate Analog Peptide, PDB code: 3ddb:

Zinc binding site 1 out of 1 in 3ddb

Go back to Zinc Binding Sites List in 3ddb
Zinc binding site 1 out of 1 in the Crystal Structure of the Catalytic Domain of Botulinum Neurotoxin Serotype A with A Substrate Analog Peptide


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Crystal Structure of the Catalytic Domain of Botulinum Neurotoxin Serotype A with A Substrate Analog Peptide within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn450

b:17.4
occ:1.00
 OE1 A:GLU262 2.0 16.9 1.0
NE2 A:HIS227 2.2 15.3 1.0
NE2 A:HIS223 2.2 15.4 1.0
N B:ARG197 2.2 20.8 1.0
O B:ARG197 2.4 18.7 1.0
OE2 A:GLU262 2.5 21.4 1.0
CD A:GLU262 2.6 18.8 1.0
C B:ARG197 2.9 20.6 1.0
CD2 A:HIS227 3.0 16.9 1.0
CA B:ARG197 3.0 21.3 1.0
CD2 A:HIS223 3.1 12.0 1.0
CE1 A:HIS223 3.2 13.3 1.0
CE1 A:HIS227 3.2 15.6 1.0
CB B:ARG197 3.6 24.7 1.0
OH A:TYR366 4.1 16.1 1.0
CG A:GLU262 4.1 16.6 1.0
N B:ARG198 4.1 20.8 1.0
OE2 A:GLU224 4.2 17.6 1.0
CG A:HIS227 4.2 14.4 1.0
CG A:HIS223 4.3 12.7 1.0
ND1 A:HIS227 4.3 15.5 1.0
ND1 A:HIS223 4.3 12.7 1.0
O B:HOH151 4.5 24.7 1.0
CE1 A:TYR366 4.5 13.4 1.0
CZ A:TYR366 4.6 14.4 1.0
OE1 A:GLU224 4.7 14.5 1.0
CB A:GLU262 4.8 14.6 1.0
CD A:GLU224 4.8 15.8 1.0
CA B:ARG198 4.9 19.3 1.0
CG2 A:THR265 4.9 12.7 1.0
CA A:GLU262 5.0 14.4 1.0

Reference:

D.Kumaran, R.Rawat, S.A.Ahmed, S.Swaminathan. Substrate Binding Mode and Its Implication on Drug Design For Botulinum Neurotoxin A Plos Pathog. V. 4 E1000 2008.
ISSN: ISSN 1553-7366
PubMed: 18818739
DOI: 10.1371/JOURNAL.PPAT.1000165
Page generated: Thu Oct 24 12:09:45 2024

Last articles

Mg in 7BNR
Mg in 7BNK
Mg in 7BMC
Mg in 7BM9
Mg in 7BM8
Mg in 7BM6
Mg in 7BL4
Mg in 7BL6
Mg in 7BL5
Mg in 7BJT
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy